TY - JOUR
T1 - Deletion of Ile1 changes the mechanism of streptokinase
T2 - Evidence for the molecular sexuality hypothesis
AU - Wang, Shunguang
AU - Reed, Guy L.
AU - Hedstrom, Lizbeth
PY - 1999/4/20
Y1 - 1999/4/20
N2 - Plasminogen (Plgn) is usually activated by proteolytic cleavage of Arg561-Val562. The new N-terminal amino group of Val562 forms a salt bridge with Asp740, creating the active protease plasmin (Pm). However, streptokinase (SK) binds to Plgn, generating an active protease in a poorly understood, nonproteolytic process. We hypothesized that the N-terminus of SK, Ile1, substitutes for the N-terminal Val562 of Pm, forming an analogous salt bridge with Asp740. SK initially forms an inactive complex with Plgn, which subsequently rearranges to create an active complex; this rearrangement is rate limiting at 4 °C. SK-Plgn efficiently hydrolyzes amide substrates at 4 °C, although ΔIle1-SK·Plgn has no amidolytic activity. ΔIle1-SK prevents formation of wild-type SK·Plgn. These results indicate that ΔIle1- SK forms the initial inactive complex with plasminogen, but cannot form the active complex. However, when the experiment is performed at 37 °C, amidolytic activity is observed when ΔIle1-SK is added to plasminogen. SDS- PAGE analysis demonstrates that the amidolytic activity results from the formation of ΔIle1-SK. Pm. To further demonstrate that the activity of ΔIle1-SK requires the conversion of Plgn to Pm, we characterized the reaction of SK with a mutant microplasminogen, Arg561Ala-μPlgn, that cannot be converted to microplasmin. Amidolytic activity is observed when Arg561Ala- μPlgn is incubated with wild-type SK at 37 °C; however, no amidolytic activity is observed in the presence of ΔIle1-SK. These observations demonstrate that the amidolytic activity of ΔIle1-SK at 37 °C requires the conversion of Plgn to Pm. Our findings indicate that Ile1 of SK is required for the nonproteolytic activation of Plgn by SK and are consistent with the hypothesis that Ile1 of SK substitutes for Val562 of Pm.
AB - Plasminogen (Plgn) is usually activated by proteolytic cleavage of Arg561-Val562. The new N-terminal amino group of Val562 forms a salt bridge with Asp740, creating the active protease plasmin (Pm). However, streptokinase (SK) binds to Plgn, generating an active protease in a poorly understood, nonproteolytic process. We hypothesized that the N-terminus of SK, Ile1, substitutes for the N-terminal Val562 of Pm, forming an analogous salt bridge with Asp740. SK initially forms an inactive complex with Plgn, which subsequently rearranges to create an active complex; this rearrangement is rate limiting at 4 °C. SK-Plgn efficiently hydrolyzes amide substrates at 4 °C, although ΔIle1-SK·Plgn has no amidolytic activity. ΔIle1-SK prevents formation of wild-type SK·Plgn. These results indicate that ΔIle1- SK forms the initial inactive complex with plasminogen, but cannot form the active complex. However, when the experiment is performed at 37 °C, amidolytic activity is observed when ΔIle1-SK is added to plasminogen. SDS- PAGE analysis demonstrates that the amidolytic activity results from the formation of ΔIle1-SK. Pm. To further demonstrate that the activity of ΔIle1-SK requires the conversion of Plgn to Pm, we characterized the reaction of SK with a mutant microplasminogen, Arg561Ala-μPlgn, that cannot be converted to microplasmin. Amidolytic activity is observed when Arg561Ala- μPlgn is incubated with wild-type SK at 37 °C; however, no amidolytic activity is observed in the presence of ΔIle1-SK. These observations demonstrate that the amidolytic activity of ΔIle1-SK at 37 °C requires the conversion of Plgn to Pm. Our findings indicate that Ile1 of SK is required for the nonproteolytic activation of Plgn by SK and are consistent with the hypothesis that Ile1 of SK substitutes for Val562 of Pm.
UR - http://www.scopus.com/inward/record.url?scp=0033586797&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033586797&partnerID=8YFLogxK
U2 - 10.1021/bi981915h
DO - 10.1021/bi981915h
M3 - Article
C2 - 10213631
AN - SCOPUS:0033586797
SN - 0006-2960
VL - 38
SP - 5232
EP - 5240
JO - Biochemistry
JF - Biochemistry
IS - 16
ER -